Diagnosis and treatment of BK virus-associated nephropathy after renal transplantation
10.3760/cma.j.issn.0254-1785.2019.10.010
- VernacularTitle: 肾移植术后BK病毒相关性肾病的诊断与治疗
- Author:
Long ZHANG
1
;
Jiangqiao ZHOU
;
Tao QIU
;
Zhongbao CHEN
;
Jilin ZOU
;
Xiaoxiong MA
Author Information
1. Department of Transplantation, Renmin Hospital of Wuhan University, Wuhan 430060, China
- Publication Type:Clinical Trail
- Keywords:
Kidney transplantation;
BK Virus;
Acute rejection
- From:
Chinese Journal of Organ Transplantation
2019;40(10):624-627
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the diagnosis and treatment of BKV nephropathy after renal transplantation.
Methods:A total of 62 patients with progressive creatinine elevation were routinely examined by blood and urine BKV-DNA. And 21 patients with positive results underwent graft biopsies for confirming a diagnosis.
Results:Among 21 cases of BKV infection, 20 cases received leflunomide in replacing mycophenolate mofetil (MMF) and a lower dose of tacrolimus. One case with urine (-) & blood (+ ) received sirolimus in replacing tacrolimus and a lower dose of MMF. Among 11 cases with urine (+ ) and blood (-), urinary BKV-DNA turned negative & creatinine decreased markedly (n=4), urinary BKV-DNA load decreased & creatinine stablized (n=4), death from pulmonary infection with hepatic & renal failure (n=1), urine BKV-DNA load decreased & creatine increased (n=1), BKV–DNA load was not re-examined in 1 case of acute rejection and hydronephrosis with elevated creatine; Among 9 cases with urine (+ ) & blood (+ ), blood BKV-DNA turned negative with urinary BKV-DNA load & creatine decreased (n=6), blood BKV-DNA load decreased & creatine stablized (n=2) and no re-examination with a stable level of creatine (n=1); One case with urine (-) & blood (+ ) was not timely treated and ultimately leading to graft loss after an onset of acute rejection.
Conclusions:BKV nephropathy may be effectively treated by decreasing immunosuppressive intensity. However, clinicians should stay on a high alert for acute rejection due to an excessive reduction of immunosuppressive agents.
